Zoetis (ZTS) Common Equity (2012 - 2026)
Zoetis (ZTS) posted quarterly Common Equity of $3.2 billion for Q1 2026, down 33.55% year-over-year from $4.9 billion in Q1 2025, and down 5.33% quarter-over-quarter from $3.4 billion in Q4 2025.
Zoetis (ZTS) Common Equity (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Common Equity for 15 consecutive years, with $3.2 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 33.55% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $3.2 billion (down 33.55% YoY), while the FY2025 annual figure was $3.4 billion, down 29.5% from the prior year.
- Common Equity eased to $3.2 billion in Q1 2026 per ZTS's latest filing, from $3.4 billion in the prior quarter.
- Across five years, Common Equity topped out at $5.4 billion in Q3 2025 and bottomed at $3.2 billion in Q1 2026.
- Historically, Common Equity has averaged $4.7 billion across 5 years, with a median of $4.8 billion in 2024.
- Annual changes were most pronounced in 2022 — Common Equity grew 13.83% — and 2026, when it tumbled 33.55%.
- Zoetis' Common Equity stood at $4.4 billion in 2022, then rose by 13.35% to $5.0 billion in 2023, then declined by 2.95% to $4.8 billion in 2024, then retreated by 29.5% to $3.4 billion in 2025, then decreased by 5.33% to $3.2 billion in 2026.
- Business Quant data shows ZTS's Common Equity at $3.2 billion in Q1 2026, $3.4 billion in Q4 2025, and $5.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 4.05 Bn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 1.81 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.15 Bn |
| Mar 31, 2026 | 3.23 Bn |
| Dec 31, 2025 | 3.42 Bn |
| Sep 30, 2025 | 5.40 Bn |
| Jun 30, 2025 | 4.98 Bn |
| Mar 31, 2025 | 4.87 Bn |
| Dec 31, 2024 | 4.84 Bn |
| Sep 30, 2024 | 5.23 Bn |
| Jun 30, 2024 | 4.96 Bn |
| Mar 31, 2024 | 5.05 Bn |
| Dec 31, 2023 | 4.99 Bn |
| Sep 30, 2023 | 5.07 Bn |
| Jun 30, 2023 | 4.62 Bn |
| Mar 31, 2023 | 4.49 Bn |
| Dec 31, 2022 | 4.40 Bn |
| Sep 30, 2022 | 4.66 Bn |
| Jun 30, 2022 | 4.58 Bn |
| Mar 31, 2022 | 4.66 Bn |
| Dec 31, 2021 | 4.54 Bn |
| Sep 30, 2021 | 4.68 Bn |